Welcome to the Center for Research and Evaluation.

RECOVER is a nationwide research initiative to address the widespread and diverse impacts of long COVID. The study aims to better define and identify long COVID and understand who is more or less likely to get long COVID after COVID-19 infection. The study team is also looking at how long COVID progresses over time, including understanding the range of recovery and potential treatments. KPGA is 1 of 86 sites across 33 states enrolling participants to join the study. This study is funded by the National Institutes of Health (NIH) and the KPGA team is led by Dr. Jennifer Gander.

The Type 1 Diabetes Education and Support (T1DES) study is a pilot randomized clinical trial among Black young adults 18 through 26 years old with Type 1 Diabetes. Participants from KPGA or GradyHealth are randomized to receive the T1DES intervention or diabetes management education. The study will assess the feasibility of the culturally tailored T1DES intervention and evaluate its effect on improving diabetes management and reducing diabetes distress. This study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH and the Helmsley Charitable Trust and is led by Dr. Teaniese “Tina” Davis.

The Connect for Cancer Prevention Study (CONNECT) aims to better understand the causes of cancer and how to prevent it. KPGA is 1 of 10 health care systems throughout the country participating in CONNECT. The study will enroll 200,000 cancer-free adults 30 through 70 years old. Participants will be asked to answer online surveys, donate blood, urine, and saliva samples, and share access to their electronic health records. This information will help researchers study health patterns that may affect cancer risk. This study is funded by the National Cancer Institute of the NIH, and the KPGA team is led by Dr. Jennifer Gander.